system: You are a contract-analysis assistant performing a span-extraction task. You are given an excerpt from a commercial contract and the name of a clause type to locate within it.

Return the exact text of the requested clause, copied verbatim from the excerpt — identical wording and punctuation, with no paraphrasing, summarising, explanation, or added commentary.

The excerpt is one window of a much longer contract and often will not contain the requested clause. If the requested clause does not appear in this excerpt, respond with exactly: Not found.

Output only the extracted clause text, or the exact string `Not found.` — nothing else.

user: Contract excerpt:
"""
Markers 3.4.1 Assessment 10 Bankruptcy Code 18 Binding Orders 3.1.5 Biomarker IP 2.1.2 Breaching Party 17.2.1 CDx Assays 3.4.1 CDx Platform Working Group 3.4.2 Chairperson 6.1.1 Competent Authority Procedures 10 ctDNA Milestone Date 8.4 Create Act 12.6 Database Renewal Term 3.1.9 Database Queries 3.1.8 ***Confidential Treatment Requested*** - 16 - Definition Section Data Subject 1.57 Decision Period 12.5 Disclosing Party 1.17 Ex-US Collaboration Agreement Whereas Clause First ctDNA Milestone Date 8.4 FMI CDx IP 12.1.5 FMI-Derived Advanced Genomic Analysis Results 3.1.8 FMI Improvement IP 12.1.2 FMI Invention 1.44 Immuno-Biomarker Discovery Platform 3.2.1 Immuno-Clinical Study Assays 0 Immunotherapy Exclusivity Period 3.2.8 Immunotherapy Testing Platform Development Budget 8.3.1 Genomic Analyses 3.1.4 Indemnified Party 14.3 Indemnifying Party 14.3 Initial Roche ctDNA Assay 8.4 Initiating Party 12.5 Investigational Markers 3.4.1 IVD Collaboration Whereas Clause Joint Invention 1.44 Materially Modified 8.3.2(i) Members 6.1.1 Molecular Information Database 3.1.8 Molecular Information Database Access 3.1.8 Non-Breaching Party 17.2.1 Payment Currency 9.3 Peremptory Notice Period 17.2.1 Products and Services 7 Profiling Renewal Term 3.1.9 Profiling Term 3.1.9 Publishing Notice 16.4 Publishing Party 16.4 Receiving Party 1.17 Related Agreements Whereas Clause Reserved Capacity 3.1.4 Reserved Capacity Fees 8.2.1.1 Roche CDx Development IP 12.1.5 Roche ctDNA Sample Results 12.1.4 Roche Immunotherapy Sample Results 12.1.3 Roche Improvement IP 12.1.2 Roche Invention 1.44 Roche-Owned Advanced Genomic Analysis Results 12.1.2 Roche's Jurisdiction 10 Sample Profiling 3.1.4 - 17 - Definition Section Sample Results 3.1.6 Second ctDNA Milestone Date 8.4 Settlement 12.5 Signature Identification 3.2.1 Suit Notice 12.5 Task Orders 3.1.3 TPP 6.1.5.2 Transaction Agreement Whereas Clause US Education Collaboration Agreement Whereas Clause 2. Grant of License 2.1 Licenses 2.1.1 Research and Development Cross License Each Party grants to the other Party during the time that a Work Stream is in effect, a non-exclusive right and license under Know-How and Patent Rights, including the Background IP, Controlled by such Party and that are necessary or useful solely to enable the other Party to perform the activities contemplated under this Agreement; […***…]. 2.1.2 Molecular Information Platform Licenses Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to FMI's Affiliates, under any intellectual property rights arising directly from the Sample Results, or the correlation of the Sample Results to patient data ("Biomarker IP") (i) to the extent such Biomarker IP becomes publicly known, for internal research purposes, (ii) to the extent such Biomarker IP becomes publicly known, to develop, make, have made, use, offer for sale, sell, import, and commercialize FMI's Products and Services relating to genomic analysis, and (iii) […***…]. Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to Affiliates, to use the Roche-Owned Advanced Genomic Analysis Results to develop, make, have made, use, offer for sale, sell, import and commercialize FMI's products and services relating to genomic analysis. FMI hereby grants to Roche a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to Roche's Affiliates under any FMI Improvements for Roche's internal research purposes and to develop, make, have made, use, offer for sale, sell, import and commercialize Roche's products and services other than diagnostic products and services. 2.1.3 Immunotherapy Testing Platform Licenses Effective after the Immunotherapy Exclusivity Period, Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable to Affiliates, license to any intellectual property arising from the Immunotherapy Testing Platform Development Program Controlled by Roche (excluding Roche Immunotherapy Sample Results) to the extent necessary ***Confidential Treatment Requested*** - 18 - for FMI to develop, make, have made, use, offer for sale, sell, import and commercialize the Immuno-Biomarker Discovery Platform, Signature Identification services, Clinical Study assays, CDx assays, or any other FMI testing or services (including that are part of the Genomic Analysis Platform). FMI hereby grants to Roche a non-exclusive, royalty-free, worldwide, perpetual, and sublicensable license to any intellectual property arising from the Immunotherapy Testing Platform Program Controlled by FMI for internal research purposes and to the extent necessary for Roche to research, develop, make, have made, use, offer for sale, sell, import and commercialize Roche products other than diagnostic products. If FMI is unable or unwilling to develop and commercialize an Immuno Clinical Study assay or CDx assay resulting from the Immunotherapy Testing Platform Development Program in a given country within the Territory as specified in an R&D Plan for any reason other than a breach of this Agreement by Roche, and on the timeline agreed to in such R&D Plan, then, effective on the end of the timeline specified in such R&D Plan, FMI hereby grants to Roche a non-exclusive, royalty-free,
"""

Extract the exact clause related to "License Grant" from the excerpt above.

assistant: Roche hereby grants to FMI a non-exclusive, royalty-free, worldwide and perpetual license, sublicensable to Affiliates, to use the Roche-Owned Advanced Genomic Analysis Results to develop, make, have made, use, offer for sale, sell, import and commercialize FMI's products and services relating to genomic analysis.